Clinical Trials · NCT00734279

Follicle-Stimulating Hormone (FSH) and the Onset of Puberty

CompletedEARLY_Phase 1Gonadorelin (Approved)
Phase
EARLY_Phase 1
Recruitment status
Completed
Sponsor
University of Utah
Enrollment
11
Start date
Mar 2006
Locations
1 site, United States
Primary endpoint
Determine the ability of the GnRH antagonist, ganirelix, to suppress nocturnal gonadotropin secretion in peripubertal boys and girls
View Gonadorelin compound reference